参麦注射液对急性冠状动脉综合征患者的影响

Effects of the Shenmai injection on acute coronary syndrome

目的:观察参麦注射液对急性冠状动脉综合征患者的血脂和Hs-CRP的影响。方法:将58例患者随机分成两组,对照组给予常规治疗,在此基础上,观察组给予参麦注射液40m L+葡萄糖注射液250m L静脉滴注,1次/d,连续两周。观察血脂和Hs-CRP的变化。结果:观察组TC、LDL-C和Hs-CRP的水平变化幅度明显大于对照组(P<0.05)。无明显的不良反应。结论:参麦注射液具有较好的抗炎和调脂作用,可稳定斑块,减少斑块破裂的发生。

Objective： To observe clinical effects of the Shenmai injection on blood fat and Hs-CRP in patients with acute coronary syndrome. Methods： 58 patients were randomly divided into two groups. The control group received conventional treatment. The observation group were given the Shenmai injection 40 m L plus the Glucose injection 250 m L through intravenous infusion, 1 time per day. The changes of blood fat and Hs-CRP were observed. Results： The changes of TC、LDL-C and Hs-CRP in the observation group were bigger than those in the control group（P〈0.05）. There was no significant adverse reactions. Conclusion： The Shenmai injection had a good anti-inflammatory and lipid-lowering effects, could stabilize plaque, and reduce the incidence of plaque rupture.